SCHEMBL6174070

SCHEMBL6174070

CC(c1ccncc1F)C1NC(=O)N(c2ccc(SC(F)(F)F)cc2)C1=O

nearest known ligand 0.39

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 11/20 0.39
LMNA P02545 1/20 0.35
AR P10275 1/20 0.32
TRPV4 Q9HBA0 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6175508 0.91 IGF1R (0.39) IGF1RLMNA
SCHEMBL6174377 0.88 IGF1R (0.40) IGF1RLMNA
SCHEMBL6173547 0.86 IGF1R (0.39) IGF1RLMNA
SCHEMBL6173990 0.86 IGF1R (0.39) IGF1RLMNA
SCHEMBL6173161 0.85 IGF1R (0.37) IGF1RLMNA
SCHEMBL6169483 0.85 IGF1R (0.38) IGF1RLMNA
SCHEMBL6173968 0.84 IGF1R (0.35) IGF1RLMNA
SCHEMBL6175512 0.84 IGF1R (0.37) IGF1RLMNA
SCHEMBL6171076 0.83 LMNA (0.48) IGF1RLMNAAR
SCHEMBL6173954 0.83 IGF1R (0.36) IGF1RLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed